Anavex Life Sciences Ownership | Who Owns Anavex Life Sciences?

Overview ForecastFinancials Chart Transcripts

Anavex Life Sciences Ownership Summary

Anavex Life Sciences is owned by 10.55% institutional investors, 3.36% insiders, and 86.09% retail investors. Blackrock funding, inc. /de is the largest institutional shareholder, holding 8.42% of AVXL shares. Vanguard US Total Market Shares ETF is the top mutual fund, with 2.98% of its assets in Anavex Life Sciences shares.

AVXL Ownership Benchmark

Type	Name	% Inst	% Insiders	% Retail
Stock	Anavex Life Sciences	10.55%	3.36%	86.09%
Sector	Healthcare Stocks	42.50%	10.81%	46.69%
Industry	Biotech Stocks	45.24%	10.75%	44.01%

Institutional Shareholders

Top Institutional Shareholders by Total Shares

Holder	Shares	% Holding	Value
Blackrock funding, inc. /de	7.19M	8.42%	$63.98M
Blackrock	6.39M	7.75%	$26.97M
Vanguard group	5.10M	5.98%	$45.43M
State street	3.29M	3.85%	$29.26M
Geode capital management	2.03M	2.37%	$18.05M
Susquehanna group, llp	1.13M	1.36%	$12.19M
Two sigma investments, lp	1.04M	1.21%	$9.23M
Nwam	874.28K	1.02%	$8.17M
Northern trust	773.01K	0.91%	$6.88M
Two sigma advisers, lp	758.50K	0.89%	$6.75M

Top Institutional Shareholders by % of Total Assets

Holder	Shares	% Assets	Value
October effect	245.22K	2.41%	$2.18M
Sheets smith investment management	135.95K	0.78%	$1.21M
Pier capital	415.91K	0.58%	$3.70M
Nwam	874.28K	0.57%	$8.17M
Allsquare wealth management	52.38K	0.27%	$482.97K
Heartland advisors	177.35K	0.08%	$1.58M
Watts gwilliam	26.00K	0.07%	$349.96K
Saxon interests	17.85K	0.07%	$153.14K
Axq capital, lp	19.10K	0.07%	$170.00K
Hikari power	85.58K	0.06%	$762.00K

Top Buyers

Holder	Shares	% Assets	Change
Susquehanna group, llp	1.13M	0.00%	896.32K
State street	3.29M	0.00%	338.31K
Franklin resources	375.22K	0.00%	302.44K
Summit financial	444.27K	0.06%	221.29K
Jane street group	218.22K	0.00%	200.54K

Top Sellers

Holder	Shares	% Assets	Change
Wealthgarden f.s.	-	-	-910.48K
Invesco	56.70K	0.00%	-807.26K
Jupiter asset management	-	-	-804.64K
Essential planning, llc.	-	-	-413.09K
Bank of america corp /de/	175.90K	0.00%	-388.80K

New Positions

Holder	Shares	% Assets	Change	Value
Sheets smith investment management	135.95K	0.78%	135.95K	$1.21M
Xtx topco	81.70K	0.04%	81.70K	$727.15K
Mariner	26.36K	0.00%	26.36K	$234.56K
Watts gwilliam	26.00K	0.07%	26.00K	$349.96K
Twinbeech capital lp	25.94K	0.01%	25.94K	$230.90K

Sold Out

Holder	Change
Twin peaks wealth advisors	-1.00
Nelson, van denburg & campbell wealth management group	-14.00
Stephens consulting	-40.00
Bay harbor wealth management	-70.00
Skopos labs	-78.00

Institutional Ownership Trends

Date	Holdings	Change %	Shares	Change %	Ownership	Change %	Increased Position	Change %	Decreased Position	Change %
Sep 30, 2025	82	-56.61%	9,007,990	-72.28%	10	0.73%	29	-68.48%	23	-34.29%
Jun 30, 2025	184	-6.60%	32,327,985	3.05%	37	2.78%	89	-11.00%	35	-23.91%
Mar 31, 2025	3	-98.38%	406,643	-98.62%	-	0.04%	2	-98.04%	-	-100.00%
Dec 31, 2024	180	17.65%	29,442,084	5.60%	34	3.11%	98	38.03%	38	22.58%
Sep 30, 2024	151	1.34%	27,864,882	4.09%	32	3.13%	72	16.13%	30	-33.33%

Top Mutual Funds Shareholders

Holder	Shares	% Holding	Change
Vanguard US Total Market Shares ETF	2.53M	2.98%	-
Vanguard Total Stock Mkt Idx Inv	2.54M	2.97%	-56.28K
iShares Russell 2000 ETF	2.02M	2.35%	-
SPDR® S&P Biotech ETF	1.12M	1.31%	2.50K
Vanguard Institutional Extnd Mkt Idx Tr	920.50K	1.08%	-413.65K
Fidelity Small Cap Index	839.44K	0.98%	77.86K
Invesco Biotechnology & Genome ETF	764.01K	0.89%	-2.40K
iShares Russell 2000 Growth ETF	737.08K	0.86%	-
iShares Russell 2000 Value ETF	507.79K	0.59%	-
iShares Biotechnology ETF	494.14K	0.58%	-

Recent Insider Transactions

Date	Name	Role	Activity	Value
Jun 14, 2024	Donhauser Peter D.O.	-	Buy	$10.32K
May 15, 2024	Thomas Steffen	-	Buy	$22.60K
Mar 28, 2024	MISSLING CHRISTOPHER U	President and CEO	Sell	$374.97K
Jun 28, 2023	MISSLING CHRISTOPHER U	President and CEO	Sell	$2.14M
May 25, 2022	Skarpelos Athanasios		Sell	$453.00K

Insider Transactions Trends

Date	Buy	Sell
2025 Q4	-	-
2025 Q3	-	-
2025 Q2	-	-
2025 Q1	-	-
2024 Q4	-	-

AVXL Ownership FAQ

Who Owns Anavex Life Sciences?

Anavex Life Sciences shareholders are primarily institutional investors at 10.55%, followed by 3.36% insiders and 86.09% retail investors. The average institutional ownership in Anavex Life Sciences's industry, Biotech Stocks , is 45.24%, which Anavex Life Sciences falls below.

Who owns the most shares of Anavex Life Sciences?

Anavex Life Sciences’s largest shareholders are Blackrock funding, inc. /de (7.19M shares, 8.42%), Blackrock (6.39M shares, 7.75%), and Vanguard group (5.1M shares, 5.98%). Together, they hold 22.15% of Anavex Life Sciences’s total shares outstanding.

Does Blackrock own Anavex Life Sciences?

Yes, BlackRock owns 7.75% of Anavex Life Sciences, totaling 6.39M shares as of Jun 2024. This represents 0.00% of BlackRock's total assets, with a market value of 26.97M$. In the last quarter, BlackRock decreased its holdings by -254K shares, a -3.82% change.

Who is Anavex Life Sciences’s biggest shareholder by percentage of total assets invested?

October effect is Anavex Life Sciences’s biggest shareholder by percentage of total assets invested, with 2.41% of its assets in 245.22K Anavex Life Sciences shares, valued at 2.18M$.

Who is the top mutual fund holder of Anavex Life Sciences shares?

Vanguard US Total Market Shares ETF is the top mutual fund holder of Anavex Life Sciences shares, with 2.98% of its total shares outstanding invested in 2.53M Anavex Life Sciences shares.

Try Tickergate Pro Free

Customize Everything. 100% Flexibility. Fast and Easy to Use (No code or Excel Needed)

Customize your own personal stocks lists, views and charts
Choose from hundreds of fields, up to 15 years of history
Conduct deep comparison analysis

Discover trending investment themes
Find your next best investment
Research stocks using tools